Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ALDS
Deeply overvalued
APPlife Digital Solutions Inc
Price$1.00
Model IV$0.25
P/IV4.04
Premium +304%
Return to IV: -75.3%
Market implies +25.8%/yr
vs model +50.0% · below model
ALDX
Valuation N/A
Aldeyra Therapeutics, Inc.
Price$0.92
Model IV—
P/IV—
Limited data — see page
ALEC
Valuation N/A
Alector, Inc.
Price$2.08
Model IV—
P/IV—
Market implies +54.9%/yr
ALF
Valuation N/A
Centurion Acquisition Corp.
Price$10.92
Model IV—
P/IV—
Limited data — see page
ALFUU
Valuation N/A
Centurion Acquisition Corp.
Price$10.91
Model IV—
P/IV—
Limited data — see page
ALFUW
Valuation N/A
Centurion Acquisition Corp.
Price$0.19
Model IV—
P/IV—
Limited data — see page
ALGS
Valuation N/A
Aligos Therapeutics, Inc.
Price$5.34
Model IV—
P/IV—
Market implies +41.6%/yr
ALIS
Valuation N/A
Calisa Acquisition Corp
Price$10.07
Model IV—
P/IV—
Limited data — see page
ALISR
Valuation N/A
Calisa Acquisition Corp
Price$0.79
Model IV—
P/IV—
Limited data — see page
ALISU
Valuation N/A
Calisa Acquisition Corp
Price$23.10
Model IV—
P/IV—
Limited data — see page
ALLR
Valuation N/A
Allarity Therapeutics, Inc.
Price$0.99
Model IV—
P/IV—
Market implies +53.9%/yr
ALMU
Valuation N/A
Aeluma, Inc.
Price$11.40
Model IV—
P/IV—
Market implies +56.3%/yr
ALOT
Valuation N/A
ALOT
Price$28.99
Model IV—
P/IV—
Limited data — see page
ALOV
Valuation N/A
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Price$10.02
Model IV—
P/IV—
Limited data — see page
ALOVU
Valuation N/A
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Price$10.06
Model IV—
P/IV—
Limited data — see page
ALOVW
Valuation N/A
Aldabra 4 Liquidity Opportunity Vehicle, Inc.
Price$0.38
Model IV—
P/IV—
Limited data — see page
ALP
Valuation N/A
Alpha Compute Corp
Price$3.97
Model IV—
P/IV—
Limited data — see page
ALPS
Valuation N/A
Alps Group Inc
Price$0.37
Model IV—
P/IV—
Limited data — see page
ALTG
Fairly valued
ALTA EQUIPMENT GROUP INC.
Price$6.34
Model IV$5.91
P/IV1.06
Premium +7%
Return to IV: -6.8%
Market implies +4.8%/yr
vs model +7.5% · in line
ALTO
Valuation N/A
Alto Ingredients, Inc.
Price$3.73
Model IV—
P/IV—
Market implies +42.9%/yr
vs model +5.0% · above model
ALUB
Valuation N/A
Alussa Energy Acquisition Corp. II
Price$10.18
Model IV—
P/IV—
Limited data — see page
ALVOW
Valuation N/A
Alvotech
Price$0.45
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +50.0% · below model
ALXO
Valuation N/A
ALX ONCOLOGY HOLDINGS INC
Price$1.25
Model IV—
P/IV—
Limited data — see page
ALZN
Valuation N/A
Alzamend Neuro, Inc.
Price$1.34
Model IV—
P/IV—
Limited data — see page
AMAN
Valuation N/A
Amanat Acquisition Corp.
Price$10.41
Model IV—
P/IV—
Limited data — see page
AMBO
Valuation N/A
Ambow Education Holding Ltd.
Price$1.85
Model IV—
P/IV—
Market implies +37.5%/yr
AMBR
Deeply overvalued
Amber International Holding Ltd
Price$1.88
Model IV$0.42
P/IV4.26
Premium +351%
Return to IV: -77.8%
Market implies +20.5%/yr
vs model +2.0% · above model
AMCI
Valuation N/A
AMC Robotics Corp
Price$2.78
Model IV—
P/IV—
Market implies +59.6%/yr
AMIX
Valuation N/A
Autonomix Medical, Inc.
Price$3.11
Model IV—
P/IV—
Limited data — see page
AMOD
Valuation N/A
ALPHA MODUS HOLDINGS, INC.
Price$2.19
Model IV—
P/IV—
Limited data — see page
AMODW
Deeply overvalued
ALPHA MODUS HOLDINGS, INC.
Price$0.02
Model IV$0.01
P/IV2.45
Premium +116%
Return to IV: -53.7%
AMPG
Undervalued
AmpliTech Group, Inc.
Price$2.84
Model IV$3.66
P/IV0.88
Discount 22%
Return to IV: +28.7%
Market implies +0.8%/yr
vs model +47.8% · below model
AMPGR
Valuation N/A
AMPGR
Price$1.25
Model IV—
P/IV—
Limited data — see page
AMPGZ
Deeply undervalued
AmpliTech Group, Inc.
Price$0.10
Model IV$3.23
P/IV0.05
Discount 97%
Return to IV: +3,031.1%
Market implies -50.0%/yr
vs model +47.8% · below model
AMPY
Deeply undervalued
Amplify Energy Corp.
Price$4.46
Model IV$7.72
P/IV0.54
Discount 42%
Return to IV: +73.0%
Market implies -11.6%/yr
vs model +0.9% · below model
AMS
Deeply undervalued
AMERICAN SHARED HOSPITAL SERVICES
Price$1.32
Model IV$3.57
P/IV0.40
Discount 63%
Return to IV: +170.5%
Market implies -21.3%/yr
vs model +12.4% · below model
AMSS
Valuation N/A
AMASS BRANDS
Price$0.34
Model IV—
P/IV—
Limited data — see page
AMST
Valuation N/A
Amesite Inc.
Price$0.88
Model IV—
P/IV—
Market implies +31.3%/yr
AMTD
Deeply undervalued
AMTD IDEA GROUP
Price$0.51
Model IV$1.72
P/IV0.42
Discount 70%
Return to IV: +235.9%
Market implies -22.7%/yr
vs model +1.6% · below model
AMTX
Valuation N/A
AEMETIS, INC
Price$1.66
Model IV—
P/IV—
Market implies +44.7%/yr
vs model +5.0% · above model
AMWL
Deeply overvalued
American Well Corp
Price$12.70
Model IV$6.94
P/IV1.90
Premium +83%
Return to IV: -45.4%
Market implies +9.6%/yr
vs model +2.0% · above model
ANGH
Deeply overvalued
Anghami Inc
Price$3.77
Model IV$1.85
P/IV2.06
Premium +104%
Return to IV: -51.1%
Market implies +9.7%/yr
vs model +26.5% · below model
ANGHW
Valuation N/A
Anghami Inc
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +26.5% · below model
ANGI
Deeply overvalued
Angi Inc.
Price$6.59
Model IV$4.17
P/IV1.37
Premium +58%
Return to IV: -36.7%
Market implies +2.8%/yr
vs model -0.4% · above model
ANIK
Deeply overvalued
Anika Therapeutics, Inc.
Price$19.58
Model IV$5.90
P/IV3.54
Premium +232%
Return to IV: -69.9%
Market implies +15.9%/yr
vs model +2.0% · above model
ANIX
Valuation N/A
Anixa Biosciences Inc
Price$2.90
Model IV—
P/IV—
Market implies +150.0%/yr
ANNA
Valuation N/A
AleAnna, Inc.
Price$2.57
Model IV—
P/IV—
Market implies +54.1%/yr
vs model +4.0% · above model
ANNAW
Deeply overvalued
AleAnna, Inc.
Price$0.25
Model IV$0.10
P/IV2.77
Premium +156%
Return to IV: -61.0%
Market implies +13.3%/yr
vs model +4.0% · above model
ANPA
Valuation N/A
Rich Sparkle Holdings Ltd
Price$1.91
Model IV—
P/IV—
Market implies +18.9%/yr
ANSC
Valuation N/A
ANSC
Price$11.46
Model IV—
P/IV—
Limited data — see page
ANSCU
Valuation N/A
ANSCU
Price$11.69
Model IV—
P/IV—
Limited data — see page
ANSCW
Valuation N/A
ANSCW
Price$0.00
Model IV—
P/IV—
Limited data — see page
ANSS
Valuation N/A
ANSS
Price$374.30
Model IV—
P/IV—
Limited data — see page
ANTA
Undervalued
Antalpha Platform Holding Co
Price$2.37
Model IV$2.99
P/IV0.77
Discount 21%
Return to IV: +26.3%
ANTX
Valuation N/A
AN2 Therapeutics, Inc.
Price$4.40
Model IV—
P/IV—
Limited data — see page
ANVS
Valuation N/A
Annovis Bio, Inc.
Price$1.21
Model IV—
P/IV—
Limited data — see page
ANY
Fairly valued
DarkHorse Technologies Inc.
Price$2.75
Model IV$2.45
P/IV1.18
Premium +12%
Return to IV: -10.8%
Market implies +2.7%/yr
vs model +31.7% · below model
AOMR
Valuation N/A
Angel Oak Mortgage REIT, Inc.
Price$7.26
Model IV—
P/IV—
Limited data — see page
AOUT
Deeply overvalued
American Outdoor Brands, Inc.
Price$16.50
Model IV$8.16
P/IV2.04
Premium +102%
Return to IV: -50.5%
Market implies +10.5%/yr
vs model +2.0% · above model
AOXY
Deeply undervalued
ADVANCED OXYGEN TECHNOLOGIES INC
Price$0.09
Model IV$0.16
P/IV0.48
Discount 44%
Return to IV: +78.0%
Market implies -9.4%/yr
vs model +4.5% · below model
